ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis.
Masanori AtsukawaAkihito TsubotaChisa KondoHidenori ToyodaKoichi TakaguchiMakoto NakamutaTsunamasa WatanabeAsahiro MorishitaJoji TaniHironao OkuboAtsushi HiraokaAkito NozakiMakoto ChumaKazuhito KawataHaruki UojimaChikara OgawaToru AsanoShigeru MikamiKeizo KatoKentaro MatsuuraTadashi IkegamiToru IshikawaKunihiko TsujiToshifumi TadaAkemi TsutsuiTomonori SenohMichika KitamuraTomomi OkuboTaeang AraiMotoyuki KohjimaKiyoshi MoritaTakehiro AkahaneHiroki NishikawaMotoh IwasaYasuhito TanakaKatsuhiko IwakiriPublished in: Journal of gastroenterology (2024)
Patients with cirrhosis can experience esophageal varices aggravation or de novo esophageal varices, despite achieving SVR. In particular, patients with high ALBI score at SVR12 have a high likelihood of developing post-SVR esophageal varices aggravation or de novo post-SVR esophageal varices.